Abstract:STUDY QUESTION: Is there an association between sperm DNA methylation profiles and asthenozoospermia? SUMMARYANSWER: DNA methylation, at specific CpGs but not at the global level, was significantly different between low motile sperm cells of asthenozoospermic individuals and high motile sperm cells of normozoospermic controls. WHAT IS KNOWN ALREADY: Aberrant DNA methylation, both globally and restricted to a specific gene locus, has been associated with male infertility and abnormal semen parameters. STUDY DESIGN, SIZE, DURATION: This was a case-control study investigating the differences in DNA methylation at CpGs in promoter regions between high and low motile sperm cells from eight normozoospermic controls and seven asthenozoospermic patients. PARTICIPANTS/MATERIALS, SETTING, METHODS: The liquid hybridization capture-based bisulfite sequencing method was used to determine DNA methylation at CpGs in promoter regions. The global inter-individual and intra-individual methylation variability were estimated by evaluating the methylation variance between and within different motile sperm fractions from the same or different individuals. Asthenozoospermia-associated differentially methylated or variable CpGs and differentially methylated regions were identified by comparing the DNA methylation of high motile sperm cells from normozoospermic controls with that of low motile sperm cells from asthenozoospermic patients. MAIN RESULTS AND THE ROLE OF CHANCE: In this study, we determined the global DNA methylation level (24.7%), inter-individual variance (14.4%) and intra-individual differences between high and low motile sperm fractions (3.9%). We demonstrated that there were no statistically signiinot signcant differences in either the global DNA methylation level or global methylation variability between sperm from men with normozoospermia or asthenozoospermia. Between high motile sperm from men with normozoospermia and low motile sperm from men with asthenozoospermia, we identified 134 differentially methylated CpGs, 41 differentially methylated regions and 134 differentially variable CpGs. The genomic distribution patterns of the differential methylation spectrum suggested that gene expression may be affected in low motile sperm cells of asthenozoospermic patients. Finally, through a functional analysis, we detected 16 differentially methylated or variable genes that are required for spermatogenesis and sperm motility or dominantly expressed in testis. LIMITATIONS, REASONS FOR CAUTION: The sample size in this study was limited, although the participants in the two groups were carefully selected and well matched. Our results must be verified in larger cohorts with the use of different techniques. Furthermore, our results were descriptive, and follow-up studies will be needed to elucidate the effect of differential methylation profiles on asthenozoospermia. WIDER IMPLICATIONS OF THE FINDINGS: Our study identified asthenozoospermia-associated DNA methylation profiles and proposed a list of genes, which were suggested to be involved in the regulation of sperm motility through an alteration of DNA methylation. These results will provide promising clues for understanding the effect of DNA methylation on sperm motility and asthenozoospermia.

Metabolomics analysis of human spermatozoa reveals impaired metabolic pathways in asthenozoospermia

Metabolic Characterization of Asthenozoospermia Using Nontargeted Seminal Plasma Metabolomics

Metabolomic signature of the seminal plasma in men with severe oligoasthenospermia

Metabolic Dysregulation and Sperm Motility in Male Infertility

Metabolomic signature of sperm in men with obesity-associated asthenozoospermia

Promoter targeted bisulfite sequencing reveals DNA methylation profiles associated with low sperm motility in asthenozoospermia.

The Activated AMPK/mTORC2 Signaling Pathway Associated with Oxidative Stress in Seminal Plasma Contributes to Idiopathic Asthenozoospermia

Comprehensive metabolomics profiling of seminal plasma in asthenozoospermia caused by different etiologies

Proteomic Analysis of Seminal Plasma from Asthenozoospermia Patients Reveals Proteins That Affect Oxidative Stress Responses and Semen Quality

Sperm motility inversely correlates with seminal leptin levels in idiopathic asthenozoospermia

Changes in seminal plasma microecological dynamics and the mechanistic impact of core metabolite hexadecanamide in asthenozoospermia patients

Serum Metabolomic Profiling Identifies Characterization Of Non-Obstructive Azoospermic Men

DNA Methylation Patterns in Patients with Asthenospermia and Oligoasthenospermia

Identification of potential biomarkers and pathways for asthenozoospermia by bioinformatics analysis and experiments

Targeted Amino Acids Profiling of Human Seminal Plasma from Teratozoospermia Patients Using LC–MS/MS

CD147 Deficiency is Associated with Impairedsperm Motility/acrosome Reaction and Offersa Therapeutic Target for Asthenozoospermia

DNA Methylation Levels of Imprinted and Nonimprinted Genes DMRs Associated with Defective Human Spermatozoa.

[Expressions of zinc homeostasis proteins, GPR39 and ANO1 mRNA in the sperm of asthenozoospermia patients and their clinical significance]

Differential Proteomic Analysis of Human Sperm: A Systematic Review to Identify Candidate Targets to Monitor Sperm Quality

A Metabolomic Profile of Seminal Fluid in Extremely Severe Oligozoopermia Suggesting an Epididymal Involvement

Impact of Oxidative Stress on Sperm Quality in Oligozoospermia and Normozoospermia Males Without Obvious Causes of Infertility